Last reviewed · How we verify
Domestic Tenofovir Disoproxil Fumarate Tablets — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Domestic Tenofovir Disoproxil Fumarate Tablets (Domestic Tenofovir Disoproxil Fumarate Tablets) — Chia Tai Tianqing Pharmaceutical Group Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Domestic Tenofovir Disoproxil Fumarate Tablets TARGET | Domestic Tenofovir Disoproxil Fumarate Tablets | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Domestic Tenofovir Disoproxil Fumarate Tablets CI watch — RSS
- Domestic Tenofovir Disoproxil Fumarate Tablets CI watch — Atom
- Domestic Tenofovir Disoproxil Fumarate Tablets CI watch — JSON
- Domestic Tenofovir Disoproxil Fumarate Tablets alone — RSS
Cite this brief
Drug Landscape (2026). Domestic Tenofovir Disoproxil Fumarate Tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/domestic-tenofovir-disoproxil-fumarate-tablets. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab